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Abstract: An abnormal colonization pattern of the preterm gut may affect immune maturation
and exert a long-term influence on the intestinal bacterial composition and host health. However,
follow-up studies assessing the evolution of the fecal microbiota of infants that were born preterm are
very scarce. In this work, the bacterial compositions of fecal samples, obtained from sixteen 2-year-old
infants were evaluated using a phylogenetic microarray; subsequently, the results were compared
with those obtained in a previous study from samples of meconium and feces collected from the same
infants while they stayed in the neonatal intensive care unit (NICU). In parallel, the concentration
of a wide range of cytokines, chemokines, growth factors and immunoglobulins were determined
in meconium and fecal samples. Globally, a higher bacterial diversity and a lower interindividual
variability were observed in 2-year-olds’ feces, when compared to the samples obtained during
their first days of life. Hospital-associated fecal bacteria, that were dominant during the NICU stay,
seemed to be replaced, two years later, by genera, which are usually predominant in the healthy
adult microbiome. The immune profile of the meconium and fecal samples differed, depending on
the sampling time, showing different immune maturation statuses of the gut.
Keywords: prematurity; infant gut microbiota; DNA microarray; immune maturation
1. Introduction
The microbial composition of the gastrointestinal tract in humans undergoes remarkable changes
in our life span [1–3]. The most dynamic period of changes in human intestinal microbiota is reported
after birth, when the scarce bacteria present in the intrauterine environment make space for a complex
microbial community. The conventional belief is that the development of the intestinal microbiota
in term infants involves early colonization by facultative anaerobes, which generate a reducing
environment, favoring the growth of strictly anaerobic bacteria [4–7]. From an initial low diversity and
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low complexity, the intestinal bacterial community of the infant will gradually develop and mature,
reaching an enduring adult state after 2–3 years of age [6,8,9].
However, the establishment and development of the intestinal microbiota differ between preterm
and healthy term infants [10,11]. In the former, several factors, including mother/infant antibiotic
therapy, Caesarean section, early separation from parents, delayed enteral feeding, invasive medical
procedures or a long stay in the neonatal intensive care unit (NICU), are assumed to exert strong
influences on early colonization of the infant gut [5,12,13]. Previous studies monitoring the bacterial
communities, using culture-dependent and independent techniques, in term and preterm infants,
have detected a reduced number of bacterial species in the fecal microbiota of preterm infants,
compared with term infants [14–16]. In healthy, full-term, vaginally-delivered newborns, gut microbial
colonization is initiated with facultative anaerobic microorganisms, which decrease the intestinal
redox potential, helping the subsequent establishment of strict anaerobic microorganisms, such as
Bifidobacterium, Bacteroides or Clostridium [8,17]. In preterm infants, the establishment of obligate
anaerobes, especially bifidobacteria, are delayed, compared with full-term infants and facultative
anaerobes, such as enterobacteria, enterococci and staphylococci, seem to persist for several weeks at
high levels in the preterm infant’s fecal microbiota [14,15,18–20]. The abnormal gut colonization in
preterm infants during their first weeks of life [14,17,21] may affect the maturation of the gut barrier as
well as its nutritional and immunological functions at that time and later [22,23].
There is circumstantial evidence that initial microbial gut colonization and the resulting immune
and metabolic programming could have a long-lasting influence on the risk for future diseases [6,24].
However, little is known about the possible influence of gut microbiota on the human immune system
and how early bacterial colonization affects immune maturation [25,26], particularly among preterm
infants [16]. Several studies have assessed immune compounds in saliva, umbilical cord blood or
peripheral blood of infants [25,27–31], but few have described the presence of cytokines, chemokines,
growth factors or immunoglobulins in fecal samples of preterm babies [32–35].
In this context, the objectives of this study were, firstly, to study if the abnormal initial colonization
of preterm babies previously studied [36] may affect their fecal bacterial composition when they are
2 years old, by using a phylogenetic microarray [37] and, secondly, to characterize and compare the
immune profiles of the meconium and infant feces, obtained from such infants in the first weeks after
birth and, also, at the age of 2.
2. Materials and Methods
2.1. Patients and Sampling
This prospective study included sixteen 2-year-old infants, who were born prematurely at the
Hospital Universitario 12 de Octubre, Madrid (Spain) (Table 1).
Table 1. Demographic data for the infant cohort.
Infant Gestational Age (week) Delivery Mode Gender Birth Weight (g)
2 30 Caesarean section Male 1550
4 27 Caesarean section Female 1080
5 30 Caesarean section Male 2030
6 30 Vaginal Male 1760
7 24 Caesarean section Female 600
9 27 Vaginal Male 1540
10 26 Caesarean section Female 790
13 32 Vaginal Female 1310
15 30 Vaginal Female 1350
18 24 Vaginal Male 740
21 28 Caesarean section Male 1100
22 31 Vaginal Female 1430
28 27 Vaginal Female 1040
29 29 Caesarean section Male 680
30 30 Vaginal Female 1370
31 28 Caesarean section Female 1150
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Written informed parental consent was obtained for each infant before inclusion in the study,
which was approved by the Ethical Committee on Clinical Research of the Hospital Clínico San Carlos
of Madrid (10/017-E). This study was conducted in accordance with the Declaration of Helsinki.
Characteristics to be eligible for enrolment have been described previously [32]. Relevant clinical data
recorded for each infant, such as length of antibiotic therapy, parenteral nutrition, nasogastric feeding,
mechanical ventilation, hospital stay and type of feeding, are described in Table 2. All infants
were fed with human milk (donor milk and/or their own mother’s milk) and, occasionally,
with preterm formula.
The medical staff from the Department of Neonatology of the hospital had collected first
spontaneously evacuated meconium and fecal samples during the infants’ stays at the NICU [36].
Later, when the infants reached 2 years of age, parents were contacted to provide an additional fecal
sample, if their infants had not taken antibiotics within the previous 2 months. All the samples were
stored at −20 ◦C until analysis and processed as described previously [36].















2 42 3 0 5 38 59
4 60 4 0.5 3 48 24
5 27 3 2 0 26 11
6 27 0 0 0 26 7
7 113 5 9 8 107 116
9 68 4 2 5 58 96
10 84 7 0.5 6 70 0
13 28 3 0 0 21 12
15 44 3 1 7 38 11
18 116 27 35 13 112 144
21 73 7 10 14 62 48
22 37 3 0 4 35 3
28 68 7 0 7 62 12
29 70 15 8 9 60 144
30 41 4 0 3 40
31 52 3 0 6 47 9
Mean (95% CI) 58.64 (41.35;75.93) 4.85 (2.66; 7.05) 52.40 (36.03; 68.82) 46.4 (17.22;75.58)
Median (IQR) 3.5 (3.0–7.0) 0.25 (0.00–1.75)
CI: Confidence interval; IQR: Inter-quartile range.
2.2. Human Intestinal Tract Chip (HITChip) Analysis
DNA extraction from fecal samples was performed following the protocol described in Moles
et al. (2013) [36]. All the steps for the HITChip microarray analysis, including polymerase chain
reaction (PCR) amplification of 16S rRNA genes, RNA production and labeling, hybridization and
data extraction, were performed as described previously [33]. Then, the PCR products were purified,
using the High Pure PCR Product Purification kit (Roche, Mannheim, Germany), according to the
manufacturer’s instructions. In vitro transcription of the T7 promoter-carrying 16S rRNA genes was
performed using the Riboprobe System (Promega, Madison, WI, USA) while amino-allyl-modified
nucleotides were coupled with CyDye using the Post-Labeling Reactive Dye (Amersham Biosciences,
Little Chalfont, UK).
Data were extracted from the microarray images, using Agilent Feature Extraction software,
version 9.1 (http://www.agilent.com), subsequently normalized, and further analyzed using a
set of R-based scripts (http://r-project.org) in combination with a custom-designed relational
database that runs under the MySQL database management system. Hierarchical clustering of
probe profiles was carried out using the Pearson’s distance and Ward’s minimum variance method.
Normalized hybridization signals for 23 Level 1 (phylum-like) groups and 131 Level 2 (genus-like)
groups, as defined previously [37], are available as Supplementary Materials in Tables S1 and
S2, respectively.
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Data, available on the HITChip database, on fecal samples from 2–4-year-old healthy children
and healthy adults were used for comparison purposes. Demographic data and other information
from the 2–4-year-old healthy children has been published previously [38]. The bacterial compositions
of fecal samples from healthy adult subjects were selected from the CO-MIC cohort, a study of the
intestinal microbiome among Irritable Bowel Syndrome patients and healthy individuals. None of the
individuals selected received antibiotics.
2.3. Immunological Analysis
The concentrations of 18 cytokines, chemokines, and growth factors, including interleukins (IL)
1β, 2, 4, 5, 6, 7, 8, 10, 12(p70), 13, and 17, interferon-gamma (IFN-γ), granulocyte colony stimulating
factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), growth regulated
oncogene-alpha (Gro-α), monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory
protein-1β (MIP-1β) and tumor necrosis factor-alpha (TNF-α), were determined in meconium and
fecal samples by using the Human Cytokine group I and II assay kits (Bio-Rad Laboratories Inc.,
Hercules, CA, USA) in a Bioplex 200 system instrument (Bio-Rad). Briefly, 0.1 g of fecal samples was
suspended in 1 mL of PBS. After homogenization, the samples were centrifuged (14,000× g, 15 min,
4 ◦C) and the supernatants (≥200 µL) were collected. Determinations in meconium and fecal samples
were carried out in duplicate.
The concentrations of immunoglobulin (Ig) G1, IgG2, IgG3, IgG4, IgM and IgA in the samples
were determined using the Bio-Plex Pro Human Isotyping Assay kit (Bio-Rad) using the Bioplex 200
system. For this purpose, the samples were conditioned, as described above, for cytokine analysis.
All analyses were carried out in duplicate, following the manufacturer’s protocol.
Calibration curves for each analyte were constructed using triplicate values for each known
concentration and the Bio-Plex Manager 6.0 software (Bio-Rad, Hercules, CA, USA).
2.4. Statistical Analysis
Quantitative data were expressed as the mean and 95% confidence interval (CI) of the mean or,
when they were not normally distributed, as the median and interquartile range (IQR). The richness and
diversity of the meconium and fecal microbiota were determined by calculating the Shannon–Weaver
diversity index, which takes into account the number and evenness of the bacterial species.
Friedman’s non-parametric repeated measures comparisons were applied to determine differences
between the hybridization signal intensities of genus-like bacterial groups across time. Chi-square
independency tests were used to evaluate differences in the detection frequencies of immune
compounds. One-way ANOVA or Kruskal–Wallis tests were used to compare differences in the
concentrations of immune compounds at different sampling times. The immune compounds were
further analyzed, applying exploratory multivariate analyses, such as the principal component analysis
(PCA), multiple discriminant analysis (MDA) and cluster analysis (CA). Differences were considered
significant at p < 0.05. Statgraphics Centurion XVI version 16.1.15 (Statpoint Technologies Inc.,
Warrenton, VA, USA) and R 2.13.2 (R Foundation for Statistical Computing, https://www.r-project.org,
Vienna, Austria) software were used to carry out the analyses cited above.
For comprehensive multivariate statistical analyses, Canoco software for Windows 5.0
(Wageningen, The Netherlands) was used [34]. A redundancy analysis was performed to assess
correlations between the microbial groups detected by the HITChip and the sample characteristics.
The log-transformed hybridization signals of 130 genus-level phylogenetic groups targeted by
the HITChip were used as biological variables. Gestational age, gender, birth weight, Z score,
vaginal vs. cesarean section, age, antibiotics (mother and/or infant), time of first passage of meconium,
type of nutrition, time of enteral and parenteral nutrition, sepsis and hospital stay were included
as explanatory variables. The Monte Carlo Permutation testing (MCPT) was used to assess the
significance of the variation in large data sets.
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To evaluate the significance of the difference between datasets not-normally distributed, p values
were calculated by Wilcoxon rank sum tests.
3. Results
3.1. Characteristics of the Infants
The 16 infants that participated in this study had, at birth, a mean gestational age of 28 weeks
(ranging from 24 to 32 weeks) and a mean birth weight of 1220 g (ranging from 600 to 2030 g) (Table 1).
Half of the infants (n = 8) were born by Cesarean section. All of them, except one, received antibacterial
prophylaxis at least for the first 3 days of life, and nine needed mechanical ventilation (Table 2).
Infants were fed either with their own mother’s milk, donor milk and/or preterm formula by
nasogastric feeding tube for, at least 21 days after delivery. The time required for spontaneous
delivery of the first meconium oscillated between the first minutes to day 6 after birth. In addition to
the meconium samples, fecal samples were available from the same infants, obtained after 3 weeks
(±21 days) and 2 years (±730 days) after birth.
3.2. HITChip Analysis
The microarray datasets of the 16 fecal samples, collected two years after birth and those
previously obtained from meconium and feces, collected in the third week of life [36] were analyzed
and hierarchically clustered, based on the signal intensity of the 3699 distinct HITChip oligonucleotide
probes (Figure 1, Table S1). The obtained unsupervised microbiota profiles clustered into three different
groups, according to the sampling times, except for those of the meconium samples of infants 4, 6 and
22 (Figure 1).
The relative contribution of the major phyla (Table S2) was assessed as the percentage of
the phylum taxa among the total microbiome detected in each fecal sample (Figure 2). Globally,
approximately two thirds of the DNA phylotypes retrieved from the meconium samples were ascribed
to the Firmicutes phylum (63.4%). The phylum Proteobacteria dominated in the 21-day fecal samples
(about 60.0%) but became a minor species in the 2-year samples (2.5%). Interestingly, Firmicutes was
again the most abundant phylum (78.5%) in the later samples, followed by Actinobacteria (9.9%) and
Bacteroidetes (7.7%).
Within the Firmicutes, those belonging to the class Bacilli were the most abundant, both in
meconium and 21-day feces (18.8%). However, the diversity of Firmicutes was notably higher in
2-year fecal samples, where Clostridium cluster XIVa (35.2%) and Clostridium cluster IV (27.1%) became
the predominant classes (Figure 3).








Figure 1. Hierarchical clustering of the intestinal microbiota. Unsupervised clustering was performed
for HITChip oligoprofiles, obtained from fecal samples of the preterm infants at meconium (0 days),
third week (21 days) and 2-years (720 days). Each line represents a different probe and the darkness of
the lines represents the probe abundance in the sample. The highest phylogenetic levels represented are
shown on the right side of the figure. Pearson’s correlation and Ward’s clustering methods were used.
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Figure 2. Development of the intestinal microbiota composition at the phylum level. The relative












Figure 3. Development of the intestinal microbiota composition at the phylum/order level. The relative
contribution is shown for the phylum/order-like phylogroups of the microbiota of meconium,
third week and 2-year fecal samples of the preterm, as assessed using the HITChip microarray.
Only phylum/order-like phylogroups that contributed at least 0.1% to a given profile are shown.
On a lower taxonomic level, the comparison of the 130 hybridization signals, corresponding to
the genus-like bacterial groups (Level 2, Table S3), obtained from the 21-day and 730-day fecal
samples, showed that 91 phylogenetic groups differed significantly between both types of samples.
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Among them, 60 phylogenetic groups contributed >0.1% to the microbial profile of each sample
(Table 3). The presence of 10 genus-like groups (Level 1) significantly decreased in the 2-year
fecal samples, compared to the 21-day ones. It should be highlighted that most of the genera
that were significantly reduced (Table 3, positive fold change ↑) are typically associated with
hospital environments, including bacteria related to Enterobacter aerogenes, Enterococus spp. E. coli,
Granulicatella spp., K. pneumoniae, and Proteus, Serratia and Yersinia spp. In contrast, there was a very
high increase (≥40-fold) from the 21-day to 2-year microbiota, in the abundance of bacteria related
to the known carbohydrate degraders, Bacteroides vulgatus, Lactococcus spp., Ruminococcus bromii and
Ruminococcus obeum as well as the butyrate producers, Anaerostipes caccae, Coprococcus eutactus and
Eubacterium hallii (Table 3, negative fold change ↓).
Table 3. Relative counts of genus-like bacterial groups. The genus-like phylogenetic groups
(Level 2; [39]), detected in fecal samples, collected at 21 days and 2 years after birth, from preterm
infants, are shown a.




Mean (95% CI) p-Value *
Fold
Change #
Actinobacteria Collinsella 0.04 (0.03; 0.04) 0.25 (0.18; 0.32) 0.009 ↑6.77
Bacteroidetes
Allistipes et rel. 0.09 (0.08; 0.11) 0.38 (0.17; 0.59) 0.009 ↑4.06
Bacteroides ovatus et rel. 0.06 (0.05; 0.07) 0.38 (0.05; 0.71) 0.009 ↑6.69
Bacteroides plebeius et rel. 0.04 (0.03; 0.04) 0.12 (0.08; 0.16) 0.009 ↑3.23
Bacteroides splachnicus et rel. 0.09(0.08; 0.11) 0.26 (0.11; 0.41) 0.016 ↑2.73
Bacteroides stercoris et rel. 0.04 (0.03; 0.04) 0.11 (0.05; 0.16) 0.009 ↑2.97
Bacteroides vulgatus et rel. 0.08 (0.05; 0.09) 3.12 (1.54; 4.70) 0.009 ↑39.50
Parabacteroides distasonis et rel. 0.06 (0.05; 0.07) 0.32 (0.16; 0.48) 0.009 ↑5.20
Prevotella melaninogenica et rel. 0.11 (0.09; 0.13) 0.88 (−0.16; 1.92) 0.033 ↑8.20
Prevotella oralis et rel. 0.04 (0.03; 0.04) 0.24 (−0.02; 0.50) 0.016 ↑6.55
Prevotella tannerae et rel. 0.02 (0.02; 0.03) 0.10 (0.07; 0.13) 0.009 ↑4.20
Tannerella et rel. 0.05 (0.04; 0.06) 0.13 (0.11; 0.16) 0.009 ↑2.63
Bacilli
Enterococcus 3.49 (−1.05; 8.03) 0.10 (0.06; 0.13) 0.009 ↓36.18
Granulicatella 1.00 (0.19; 1.80) 0.02 (0.01; 0.02) 0.009 ↓61.31
Lactococcus 0.02 (0.01; 0.02) 0.73 (−0.02; 1.48) 0.056 ↑41.05
Staphylococcus 0.19 (−0.05; 0.43) 0.02 (nd) 0.033 ↓10.86
Streptococcus intermedius et rel. 0.04 (0.02; 0.05) 0.15 (0.11; 0.20) 0.033 ↑3.96
Clostridium cluster III Clostridium stercorarium et rel. 0.03 (0.03; 0.04) 0.28 (0.15; 0.41) 0.009 ↑9.26
Clostridium cluster IV
Clostridium cellulosi et rel. 0.13 (0.11; 16) 3.49 (1.20; 5.79) 0.009 ↑26.48
Clostridium leptum et rel. 0.18 (0.09; 0.28) 2.16 (0.74; 3.57) 0.009 ↑11.81
Clostridium orbiscindens et rel. 1.03 (−0.68; 2.73) 5.59 (3.90; 7.29) 0.042 ↑5.44
Faecalibacterium prausnitzii et rel. 0.17 (0.14; 0.20) 5.02 (1.81; 8.22) 0.009 ↑29.35
Oscillospira guillermondii et rel. 0.15 (0.13; 0.18) 3.10 (−0.13; 6.32) 0.009 ↑20.04
Papillibacter cinnamivorans et rel. 0.06 (0.05; 0.07) 0.50 (0.34; 0.66) 0.009 ↑8.56
Ruminococcus bromii et rel. 0.02 (0.02; 0.03) 1.31 (0.20; 2.43) 0.009 ↑52.65
Ruminococcus callidus et rel. 0.08 (0.07; 0.09) 0.86 (−0.06; 1.78) 0.009 ↑10.57
Sporobacter termitidis et rel. 0.16 (0.14; 0.19) 1.89 (0.96; 2.81) 0.009 ↑11.56
Subdoligranulum variable at rel. 0.11 (0.09; 0.13) 2.98 (1.48; 4.48) 0.009 ↑27.51
Clostridium cluster IX Dialister 0.05 (0.02; 0.07) 0.75 (−0.03; 1.54) 0.009 ↑16.10
Clostridium cluster XI Anaerovorax odorimutans et rel. 0.05 (0.04; 0.06) 0.41 (0.27; 0.55) 0.009 ↑7.79
a Relative counts (log-transformed hybridization signals) are expressed as the mean and 95% confidence interval.
nd, no data. ¥ The genus-like phylogenetic groups shown, contributed at least 0.1% to the microbial profile of a
given sample. * t-tests were used to evaluate differences in the hybridization signal intensities of genus-like bacterial
groups across time. # Fold changes were calculated as log-transformed hybridization signals at 2 years over those at
3 weeks.
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Table 3. Cont.









Anaerostipes caccae et rel. 0.09 (0.05; 0.12) 3.94 (2.10; 5.77) 0.009 ↑45.14
Bryantella formatexigens et rel. 0.14 (0.08; 0.21) 0.69 (0.50; 0.89) 0.009 ↑4.82
Butyrivibrio crossotus et rel. 0.16 (0.09; 0.23) 1.41 (1.14; 1.68) 0.009 ↑8.89
Clostridium colinum et rel. 0.05 (0.04; 0.06) 0.14 (0.06; 0.23) 0.009 ↑2.77
Clostridium sphenoides et rel. 0.12 (0.09; 0.14) 0.85 (0.56; 1.14) 0.009 ↑7.38
Clostridium symbiosum et rel. 0.22 (0.13; 0.32) 1.81 (1.38; 2.24) 0.009 ↑8.09
Coprococcus eutactus et rel. 0.08 (0.06; 0.09) 4.96 (2.87; 7.04) 0.009 ↑64.93
Dorea formicigenerans et rel. 0.16 (0.08; 0.23) 2.63 (1.86; 3.40) 0.009 ↑16.72
Eubacterium hallii et rel. 0.04 (0.02; 0.06) 2.23 (1.40; 3.05) 0.009 ↑52.41
Eubacterium rectale et rel. 0.06 (0.04; 0.08) 0.42 (0.26; 0.58) 0.009 ↑7.09
Eubacterium ventriosum et rel. 0.05 (0.02; 0.07) 0.28 (0.13; 0.42) 0.009 ↑6.00
Lachnobacillus bovis et rel. 0.07 (0.05; 0.07) 0.31 (0.26; 0.36) 0.009 ↑4.43
Lachnospira pectinoschiza et rel. 0.10 (0.07; 0.13) 0.40 (0.28; 0.53) 0.009 ↑4.08
Roseburia intestinalis et rel. 0.03 (0.01; 0.05) 0.24 (0.15; 0.34) 0.009 ↑7.86
Ruminococcus lactaris et rel. 0.03 (0.02; 0.03) 0.42 (−0.18; 1.02) 0.009 ↑16.30
Ruminococcus obeum et rel. 0.26 (0.21; 0.31) 11.42 (8.18; 14.66) 0.009 ↑43.96
Uncultured
Clostridiales
Uncultured Clostridiales I 0.17 (0.14; 0.20) 1.11 (0.12; 2.10) 0.009 ↑6.48
Uncultured Clostridiales II 0.18 (0.16; 0.21) 0.36 (0.21; 0.51) 0.009 ↑1.97
Uncultured
Mollicutes Uncultured Mollicutes 0.08 (0.07; 0.10) 0.32 (−0.07; 0.70) 0.022 ↑3.94
Proteobacteria
Burkholderia 0.01 (nd) 0.10 (−0.04; 0.24) 0.016 ↑10.98
Enterobacter aerogenes et rel. 14.82 (8.07; 21.57) 0.21 (0.10; 0.32) 0.009 ↓69.90
Escherichia coli et rel. 37.06 (24.37; 49.76) 0.82 (−0.25; 1.88) 0.009 ↓45.41
Klebisiella pneumoniae et rel. 15.75 (10.18; 21.32) 0.11 (0.05; 0.18) 0.009 ↓138.34
Oxalobacter formigenes et rel. 0.02 (0.02; 0.03) 0.17 (0.02; 0.32) 0.009 ↑7.35
Proteus et rel. 0.29 (0.17; 0.42) 0.09 (0.05; 0.12) 0.009 ↓3.46
Serratia 5.18 (1.88; 8.49) 0.15 (−0.04; 0.33) 0.009 ↓35.00
Sutterella wadsworthia et rel. 0.08 (0.07; 0.10) 0.23 (0.07; 0.39) 0.009 ↑2.79
Vibrio 0.11 (0.08; 0.15) 0.04 (0.03; 0.04) 0.009 ↓2.94
Yersinia et rel. 1.16 (0.63; 1.68) 0.04 (0.03; 0.04) 0.009 ↓31.05
Verrucomicrobia Akkermansia 0.06 (0.00; 0.13) 0.62 (0.34; 0.91) 0.016 ↑9.64
a Relative counts (log-transformed hybridization signals) are expressed as the mean and 95% confidence interval.
nd, no data. ¥ The genus-like phylogenetic groups shown, contributed at least 0.1% to the microbial profile of a
given sample. * t-tests were used to evaluate differences in the hybridization signal intensities of genus-like bacterial
groups across time. # Fold changes were calculated as log-transformed hybridization signals at 2 years over those at
3 weeks.
The comparison of genus-like bacterial groups (level 2) obtained from the 730-day fecal samples
of preterm infants and 2–4-year-old term infants showed differences in 65 genus-like bacterial groups
(Supplementary Materials Table S4) belonging to five different phyla: Actinobacteria, Bacteroidetes,
Firmicutes, Fusobacteria and Proteobacteria. Almost all the Firmicutes, the majority butyrate-producing
bacteria were more abundant in 2-year-old children born preterm, than those born at term. In contrast,
lactic acid bacteria accounted for a higher amount of the hybridization signal in children born at term
represented by Lactobacillus plantarum et rel. The genus, Bifidobacterium, accounted for less than 0.1%
of the total hybridization signal in 2-year-old children, born preterm, while in 2–4-year-old children,
born at term, levels were high [38].
The Shannon–Weaver diversity indices, obtained from meconium, 21-day and 2-year fecal samples
were compared with data available on the HITChip database for fecal samples from 2–4-year-old
healthy infants and, also, from healthy adults (Figure 4). The microbial diversity increased with age,
both in preterm and healthy individuals. Diversity indices differed significantly among all the groups,
except for (a) the meconium and 21-day samples, and (b) the 2-year samples obtained in this study and
the data from 2–4-year-old healthy infants existing in the HITChip database (paired t-test; p = 0.511
and p = 0.957 respectively).










The  relationships  between  the  observed  differences  in  the  bacterial  profiles  detected  in 
meconium, 21‐day and 2‐year feces, and several demographic and clinical variables (Tables 1 and 2), 
were explored with a multivariate cluster analysis. A redundancy analysis revealed that, among all 
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The relationships between the observed differences in the bacterial profiles detected in meconium,
21-day and 2-year feces, and several demographic and clinical variables (Tables 1 and 2), were explored
with a multivariate cluster analysis. A redundancy analysis revealed that, among all variables explored,
only the age of the infant had a significant effect on the bacterial community composition at the
different sampling times (p = 0.006, Monte Carlo Permutation Procedure) (Figure 5). More specifically,
the observed distribution could explain 41.4% of the total variation in the dataset (Figure 5).
Bacterial groups that were positively associated with increased age included bacteria belonging
to butyrate-producing species, such as Butyrivibrio crossotus, Eubacterium rectale and Eubacterium hallii.
In contrast, the groups that were negatively associated with age included potentially pathogenic
Gram-negative bacteria, typically related to hospital environments, such as Escherichia, Klebsiella,
Serratia and Yersinia. The uniform length of all vectors depicted in Figure 5 indicates that the strength
of the correlation was similar for all bacterial species. The length of the hospital stay was also found
to be associated (although not significantly) with 21-day fecal samples and with specific bacterial
groups (most notably the Proteobacteria). None of the other variables significantly influenced the
sample separation.
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Figure 5. Correlation analysis for the intestinal microbiota. The results of a redundancy analysis are
shown for the bacterial composition of meconium (blue circles), third week (red squares) and 2-year
(green rhombus) fecal samples of the preterm infants. Arabic numbers indicate the different infants.
Gray arrows indicate the bacterial groups associated with the different samples. The plotted first and
second ordination axes explained 41.4% of the variability in the data set. Age was the only variable
that was significantly related t the sample distribution (p = 0.006, Monte Carlo Permutation Testing
(MCPT) with forward selection).
3.3. Immunological An lysis
The concentration of a broad range of immune compounds, including cytokines, chemokines,
growth factors and immunoglobulins was measured in nine meconium and 9, 15 and 16 fecal samples
from the first week, third week and second year of life, respectively. Initially, an exploratory screening
was performed, in ord r to detect outliers; this analysis revealed that the 2-year f cal sa ple from
infant 2 was very different fr m the rest o the sample set in the PCA analysis of immune compounds.
The medical history from this infant reflected a high incidence of acute otitis media during the first two
years of life and, in fact, a few days after the collection of this fecal sample, this infant was submitted to
an emergency surgery. Therefore, this sample was excluded from the general immunological analysis.
Globally, the values obtained for all these immune factors showed high interindividual variability,
in both detection frequencies and concentration. Meconium samples showed a lower presence of
immune-related compounds, compared to fecal samples, except for MIP-1β and GM-CSF (Table 4).
Most cytokines related to either innate or acquired immunity were detected in less than 50% of the
samples, except for IL-1β, in the first and third weeks of life; IL-4 (for which det tion frequency
increased over ime); and IL-17 in the third w ek and after two y ars fr m birth. Among the
chemokines, MCP-1 (2-year samples) and MIP-1β (meconium, first a d third week fecal samples)
were also detected in more than 50% of the samples, while the hematopoietic factors, G-CSF and
GM-CSF, were detected in higher numbers (Table 4). All the detection frequencies (except those for
IL-6 and IL-13) changed significantly (p < 0.018) depending on the sampling time (Table 4). However,
only GM-CSF showed a statistically significant difference (p = 0.002), with higher levels in meconium
and 2-year samples, when the evolution over time of the concentrations of all the immune compounds
was considered (Table 4). Some immune compounds (IL-1β, IL-2 and MIP-1β) showed a decreasing
tendency, while others (IL-6, IL-12(p70), IFN-γ, TNF-α, MCP-1 and IL-5) tended to increase over time.
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The concentrations of IgG1, IgG2, IgG3, IgG4, IgM and IgA in meconium and fecal samples,
taken at 7, 21 and 730 days after birth, are shown in Table 5. With the exception of IgA, a high degree of
variability and a low frequency of detection were observed for immunoglobulins. Similarly to cytokines,
the detection frequencies of all the immunoglobulins changed significantly, depending on the sampling
time but no statistically significant differences were found in relation to their concentrations. IgA was
the most abundant immunoglobulin in all the tested samples with a significant change (p = 0.004) over
time. The median IgA concentrations in the first week fecal samples (26.62 mg/g) were approximately
26 times higher than those detected in the meconium ones (1.02 mg/g); the concentration then
decreased in the later time samples.
Immune profiles of fecal samples, collected at 21 and 720 days after delivery of preterm infants,
were compared with immune profiles of fecal samples collected at 90 and 300 days after delivery
of healthy infants born at term. Despite the difference between time of collection of the samples,
interesting divergences were observed. Both concentration and frequency of detection of cytokines
were higher in fecal samples of preterm infants than in infants born at term. On the other hand,
the frequency and the concentration of immunoglobulins were higher in fecal samples of infants born
at term than preterm, except for IgA.
When a multiple discriminant analysis (MDA) was applied to all the variables, taking sampling
time as the discriminant factor, two derivative functions with an eigenvalue >1 were obtained.
The predictive power of the MDA was 85.42% and the expression of the first derivative function
(Function 1) had a canonical correlation factor of 0.9018 that was statistically significant (p = 0.002).
The standardized coefficients for this function were the following: IL-1b (−0.96), IL-2 (−3.38),
IL-4 (1.22), IL-5 (−0.56), IL-6 (−0.48), IL-7 (−1.72), IL-8 (−2.81), IL-10 (−4.56), IL-12(p70) (4.50),
IL-13 (−1.10), IL-17 (−5.61), G-CSF (4.38), GM-CSF (−0.67), IFN-γ (4.49), MCP-1 (0.81), MIP-1β
(8.88), TNF-α (1,60), GRO-α (−4.78), IgG1 (2.13), IgG2 (−6.37), IgG3 (−2.71), IgG4 (−0.50), IgM (0.36),
IgA (0.30). In fact, the MDA representation allowed a differential classification of fecal samples,
according to infant age, when considering their profiles of immune compounds (Figure 6). Furthermore,
the centroid of each group of samples (meconium, first week, third week and 2-year feces) was located
in a different quadrant of the coordinates delimitated by the zero values of the axes (Figure 6).
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Table 4. Immunological analysis of intestinal samples. The presence and concentrations are shown for cytokines and other immune compounds in the meconium and








(n = 15) p-Value ] p-Value }
n (%) 1 Median (IQR) n (%) Median (IQR) n (%) Median (IQR) n (%) Median (IQR)
Innate immunity
IL-1β 2 (22.22) 1.24 (0.68–1.80) 7 (77.78) 0.13 (0.05–0.30) 13 (86.67) 0.05 (0.03–0.38) 0 - 0.000 0.520
IL-6 1 (11.11) 0.03 2 (22.22) 0.02 (0.02–0.03) 3 (20.00) 0.05 (0.05–0.71) 4 (26.67) 0.3 (0.15–0.47) 0.094 0.255
IL-12p70 1 (11.11) 0.06 2 (22.22) 0.11 (0.08–0.15) 4 (26.67) 0.07 (0.05–0.12) 4 (26.67) 0.84 (0.28–1.38) 0.018 0.601
IFN-γ * 0 - 0 - 1 (6.67) 3.27 3 (20.00) 9.27 (−7.44; 25.98) 0.000 0.521
TNF-α 1 (11.11) 0.14 2 (22.22) 0.15 (0.13–0.17) 5 (33.33) 0.18 (0.10–0.25) 3 (20.00) 0.27 (0.17–0.43) 0.002 0.934
Acquired immunity
IL-2 1 (11.11) 0.92 1 (11.11) 0.09 2 (13.33) 0.04 (0.03–0.05) 4 (26.67) 0.04 (0.02–0.15) 0.003 0.373
IL-4 4 (44.44) 0.01 (0.00–0.01) 6 (66.67) 0.01 (0.00–0.01) 11 (73.33) 0.01 (0.00–0.01) 15 (100.00) 0.01 (0.00–0.01) 0.000 0.292
IL-10 0 - 1 (11.11) 0.03 1 (6.67) 0.04 4 (26.67) 0.03 (0.02–0.23) 0.000 0.675
IL-13 * 1 (11.11) 0.03 1 (11.11) 0.05 2 (13.33) 0.08 (−0.10; 0.26) 1 (6.67) 0.05 0.568 0.571
IL-17 4 (44.44) 3.09 (2.32–3.31) 2 (22.22) 0.08 (0.05–0.12) 9 (60.00) 0.07 (0.03–0.19) 12 (80.00) 0.08 (0.04–0.06) 0.000 0.122
Chemokines
IL-8 * 4 (44.44) 0.07 (−0.08; 0.21) 1 (11.11) 0.05 3 (20.00) 0.09 (−0.02; 0.20) 0 - 0.000 0.865
MCP-1 3 (33.33) 0.03 (0.02–0.03) 1 (11.11) 0.03 4 (26.67) 0.05 (0.03–0.06) 9 (60.00) 0.19 (0.06–0.88) 0.000 0.080
MIP-1β 6 (66.67) 0.62 (0.05–1.78) 6 (66.67) 0.05 (0.04–0.16) 8 (53.33) 0.07 (0.02–0.10) 2 (13.33) 0.05 (0.04–0.07) 0.000 0.639
GRO-α 3 (33.33) 0.18 (0.16–8.28) 0 (0.00) - 6 (40.00) 0.16 (0.11–0.19) 3 (20.00) 0.14 (0.13–0.22) 0.000 0.537
Hematopoyetic factors
IL-5 * 0 - 0 - 1 (6.67) 0.03 5 (33.33) 0.25(0.03; 0.47) 0.000 0.322
IL-7 1 (11.11) 0.03 1 (11.11) 0.04 3 (20.00) 0.03 (0.02–0.05) 0 - 0.000 0.766
G-CSF 4 (44.44) 1.64 (0.34–4.29) 6 (66.67) 0.06 (0.04–0.17) 12 (80.00) 0.28 (0.15–0.55) 12 (80.00) 0.14 (0.11–0.46) 0.000 0.220
GM-CSF 9 (100.00) 0.59 a (0.28–55.03) 7 (77.78) 0.23
ab
(0.12–0.40)
15 (100.00) 0.23 ab (0.18–0.26) 15 (100.00) 0.67 ac (0.62–0.87) 0.000 0.002
Concentrations (ng/g feces) are expressed as median and interquartile range (IQR). 1 n (%): number of samples in which the parameter was detected (relative frequency of detection).
] Chi-squared tests were used to evaluate differences in expression frequencies of the analyzed parameters. } One-way ANOVA or Kruskal–Wallis tests were used to evaluate differences in
concentration across time. Different superscript letters show which medians were different within groups. * These data sets were normally distributed and concentrations are expressed as
mean and 95% CI.
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(n = 15) p-Value ] p-Value }
n (%) 1 Median (IQR) n (%) Median (IQR) n (%) Median (IQR) n (%) Median (IQR)
IgG1 4 (44.44) 0.03 (0.02–0.06) 2 (22.22) 0.34 (0.18–0.50) 3 (20.00) 0.32 (0.17–0.76) 1 (6.67) 0.06 0.000 0.621
IgG2 6 (66.67) 1.54 (0.84–3.39) 7 (77.78) 0.99 (0.84–1.19) 3 (20.00) 0.35 (0.27–0.62) 2 (13.33) 0.34 (0.24–0.44) 0.000 0.062
IgG3 * 0 - 1 (11.11) 0.01 0 - 2 (13.33) 0.01 (−0.01; 0.03) 0.000 0.326
IgG4 * 2 (22.22) 0.00 (−0.01; 0.01) 3 (33.33) 0.01 (−0.00; 0.02) 1 (6.67) 0.00 1 (6.67) 0.01 0.000 0.510
IgM 1 (2.08) 0.55 6 (12.50) 2.27 (0.53–5.14) 11 (22.92) 0.54 (0.33–0.88) 1 (6.67) 0.08 0.000 0.368
IgA 5 (55.56) 1.02 a (0.48–67.45) 8 (88.89) 26.62 ab (10.42–58.88) 15 (100.00) 6.24 ab (3.69–26.13) 13 (86.67) 1.13 ac (0.81–3.18) 0.000 0.004
Concentrations (mg/g feces) arere expressed as median and interquartile range (IQR). 1 n (%): number of samples in which the parameter was detected (relative frequency of detection).
] Chi-squared tests were used to evaluate differences in expression frequencies of the analyzed parameters. } One-way ANOVA or Kruskal–Wallis tests were used to evaluate differences in
concentration across time. Different superscript letters show which medians were different within groups. * These data sets were normally distributed and concentrations are expressed as
mean and 95% CI.




Figure  6.  Multiple  discriminant  analysis  (MDA)  of  the  immune  data. MDA was  applied  to  the 
immunological data of meconium (blue circles), first week (red squares), third week (orange cross), 
and 2‐year  (green  rhombus)  feces,  taking  sampling  time as  the discriminant  factor. The  red cross 
represents  the mathematical  centroid  for  each  sampling  time group  (meconium,  first week,  third 
week, and 2‐year fecal samples). The first and second functions, which were plotted as the x and y 
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Figure 6. Multiple discriminant analysis (MDA) of the immune data. MDA was applied to the
immunological data of meconium (blue circles), first week (red squares), third week (orange cross),
and 2-yea (gr en r o bus) feces, taking sampling time as the discriminant factor. The red cross
represents the mathematical centroid for each sampling time group (meconium, first week, third week,
and 2-year fecal samples). The first and second functions, which were plotted as the x and y axes, had a
predictive power of 85% and internal axes (pink lines) match the zero values for both functions.
4. Discussion
In this study, the bacterial compositions of fecal samples obtained from 2-year-old infants that
were born preterm were assessed and compared to those from meconium and third week of life fecal
samples obtain d fr m the same infants [36,40,41]. In addition, wide range of cytokines, chemokines,
growth factors and immunoglobulins were determined in all the meconium and fecal samples, in order
to describe their immunological profiles, their changes over time and their potential relationships with
bacterial colonization.
The results tained from meconium and third week fecal samples showed a low diversity of
bacterial species and high interindividual variability, while the opposite was observed in those taken
from the same infants at the age of 2. Globally, the bacterial communities evolved towards an adult-like
microbiota, which is the normal evolution of the microbiome of healthy term infants as they age [9,42].
Fecal sampl s taken 2 years after birth showed a distinctive bacterial comp sition when compared to
that obtained from the same infants when they were 3-weeks-old. Those genera, related with a hospital
environment—such as E. coli, Klebsiella or Serratia—and present in the third week of life seemed to be
replaced, two years later, by genera belonging to Clostridium clusters, IV and XIVa. The predominance
of such gener is a feature of the healthy adult gut microbiome, as a part of a c m l x microbiota,
which is characterized by slow turnover, preference for low redox potential and high production of
short chain fatty acids [43].
In this study, bacterial diversity increased with age, in agreement with previous works that have
reported th the number of operational taxonomic units (OTUs) detected in fecal samples increases
with age in different human populations [9]. The Shannon diversity index of the microbiota, present in
2-year-old infant stools was higher than that observed in the 21-day ones, similar to that calculated
from the 2–4-year-old healthy infants from the HITChip database, and lower to that of healthy adults,
as deduced using the same database. Remarkable changes occur in the gut colonization pattern
throughout the first two or three years of life, but then, the microbiota stabilizes and starts to resemble
that of adulthood [8,44]. The results of this study indicate that the diversity of the gut microbiota of
2-year-old infants, who were born preterm, has not yet reached the attributes of the adult microbiome.
Colonization of the infant gut by Lactobacilli and Bifidobacteria is often delayed or even absent in
the case of antibiotic-treated infants [12,15,45], including preterm neonates [36]. The results obtained
in this study indicate that this may be a long-lasting effect of prematurity, since, after two years
from birth, the relative abundance of Lactobacilli was still low, compared to age-matched term infants
(Supplementary Materials Table S4).
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Previous studies, focused on the detection and quantification of cytokines, chemokines and
immunoglobulins in blood samples, from term and preterm infants, have shown that there are
differences in their immune profiles, depending on their gestational age [27,29,31]. However, as far as
we know, this is the first study where a wide range of immune compounds has been assessed in the
meconium and feces of preterm infants and followed up when they were 2 years old. Interestingly,
each type of sample (meconium, 7-day, 21-day and 2-year feces) showed a different immune pattern
and, in fact, the MDA analysis, performed with all the immune variables, exhibited a high predictive
power, highlighting the differences in the immune profiles among the different sampling times.
In this study, the median IgA concentration increased notably from meconium to first week feces
but in the third week of life, there was a progressive reduction, although not significant, reaching levels
similar to those of healthy infants [46,47]. This probably results from the massive arrival of bacteria
and other antigens to the gut after birth, since microbial gut colonization triggers the production
of IgA by the gut-associated lymphoid tissue (GALT) [48]. This high IgA concentration in the first
weeks of life became lower in the 2-year samples. In addition, lactating mammary glands are part
of the secretory immune system, and IgA antibodies in breast milk reflect the antigenic stimulation
of mucosal-associated lymphoid tissue [49]. Breast-milk antibodies are, thus, highly targeted against
infectious agents and other exogenous antigens in the mother’s environment, which are those likely
to be encountered by the infant [32]. Therefore, breastfeeding represents an ingenious immunologic
mother–infant integration [49–52]. This fact highlights the importance of the availability of own
mother’s or donor’s milk to feed preterm neonates, a population particularly sensitive to infectious
and inflammatory diseases. It should be noted that an abnormal gut microbial colonization predisposes
the neonatal intestine to inflammation and to a cascade of pro-inflammatory and anti-inflammatory
cytokine responses [53]. The ability of IgA to penetrate the gut mucosal surface, in conjunction
with antigens and, as a consequence, to induce effector immune responses, plays a key role in the
maintenance of intestinal microbiota and immune homeostasis [54].
The comparison of the immune profiles of fecal samples of preterm infants, collected at 720 days
after delivery, with samples from infants born at term, collected at day 300, suggested a higher
activity of B lymphocytes in the latter. This fact may be associated with a higher secretory maturity,
whereas 2-year-old children born preterm have a higher activity of mediators of the immune system,
which may be associated with a high activity of T lymphocytes.
Work is in progress to characterize the wide collection of bacterial isolates obtained from the
biological samples analyzed in this study and, therefore, to elucidate at the strain or clone level if
initial colonizers may persist later in life.
5. Conclusions
Hospital-associated fecal bacteria, dominant during NICU stay are replaced, two years later,
by adult-like genera. In contrast to infants born at term, preterm infants have a low abundance of
lactobacilli and bifidobacteria at two years of age. The immune profiles of the meconium and fecal
samples differed, depending on the sampling time, showing different immune maturation statuses of
the gut.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6643/9/12/1293/s1,
Table S1: L1 HITChip composition, Table S2: L2 HITChip composition, Table S3: Oligoprofile HITChip composition,
Table S4: Relative counts of significant different genus-like bacterial groups of preterm and at term 2-year-old
children (p < 0.05).
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